Rodec Pharma IPO

Rodec Pharma IPO is a book-built issue consisting entirely of an Offer for Sale (OFS) of up to 56.50 lakh equity shares. The equity shares are proposed to be listed on BSE and NSE.

Khambatta Securities Limited is the book-running lead manager to the issue, and Bigshare Services Private Limited is the registrar. For detailed information on the company's financials, business operations and associated risks, investors are advised to refer to the Rodec Pharma IPO DRHP.

About Rodec Pharma Limited

Rodec Pharma Limited is an Indian animal healthcare and veterinary pharmaceutical company engaged in the manufacturing, marketing and distribution of veterinary medicines, feed supplements and animal health products. The company caters to the livestock and poultry sectors, supporting animal health management, disease prevention and productivity enhancement across multiple regions of India.

The company has established a diversified product portfolio comprising veterinary pharmaceuticals, nutritional supplements and other healthcare solutions for animals. Its products are marketed through an extensive distribution network covering key livestock markets, enabling it to serve veterinarians, distributors, dealers and farmers across the country.

Rodec Pharma derives its revenue from the sale of both manufactured and traded products. The company has built a strong presence in North India while steadily expanding its footprint across the eastern, western and central regions. For the financial year ended March 31, 2025, the company recorded revenue from operations of ₹1,063.93 million, reflecting growth from ₹884.21 million in FY2024 and ₹716.13 million in FY2023.

The company operates in the animal health and veterinary pharmaceutical industry, which is supported by increasing livestock populations, rising awareness regarding animal healthcare, improved disease management practices and growing demand for quality protein products. Rodec Pharma focuses on expanding its product portfolio, strengthening its distribution network and deepening its market presence to capitalise on opportunities in the evolving animal healthcare sector.

The company’s growth strategy is centred on widening geographical reach, introducing new products, strengthening relationships with distributors and veterinarians, and improving operational efficiency. By leveraging its industry experience and established market network, Rodec Pharma aims to expand its position within India's veterinary healthcare market.